Flanigan M J, Lim V S, Redlin J
Department of Medicine, University of Iowa College of Medicine, Iowa City, USA.
Adv Ren Replace Ther. 1995 Oct;2(4):330-40. doi: 10.1016/s1073-4449(12)80031-8.
Diet and nutrition are integral to the management of individuals with renal disease. Uremia engenders anorexia, nausea, meat aversion, and emesis, disturbances that ultimately reduce appetite and cause weight loss and malnutrition. Protein restriction can alleviate these uremic symptoms and improve patient health and vigor, but overly zealous protein restriction may, itself, produce malnutrition. This is particularly likely when energy intake is restricted by either design or anorexia. End-stage renal disease patients require renal replacement therapy for survival, and although dialysis is life sustaining, it neither replaces normal kidney function nor obviates the need for dietary management. In this setting of controlled, persistent uremia, undernutrition can develop surreptitiously. Dialysis physicians have long regarded malnutrition as a sign of uncontrolled uremia and failing health. This supposition has now been validated by epidemiologic studies demonstrating that serum albumin and protein catabolic rate (PCR) discriminate between dialysis patients at high and low risk of death or illness. This correlation of undernutrition with health and survival persists across wide ranges of age, medical diagnoses, and dialysis prescriptions. Because PCR is readily measured using urea kinetic analyses, it has been promoted as a patient monitoring tool and under steady-state conditions it is a reliable method of determining protein intake. Although a single PCR measurement does not integrate day-to-day dietary and metabolic fluctuations and contains an inherent uncertainty of +/- 20%, sequential measurements can be used to assess changes in an individual's dietary protein intake. PCR defines nitrogen losses and, when normalized to a realistic index of metabolic activity (metabolically active body size), it can disclose subtle individual variances in nitrogen utilization. These normalized protein catabolic rates (NPCR) do not, however, measure or describe overall nutrition. The normalization schemes employed are based on population averages and only approximate an individual's true metabolic activity. Thus, using NPCR to define nutritional needs can result in overfeeding obese and underfeeding wasted subjects. Instead, nutritional adequacy should be defined by clinical inspection and comparison with defined standards. Once that state is defined, and desirable protein and calorie intakes are determined, NPCR can be used to monitor the patient's ability to maintain homeostasis.
饮食与营养对于肾病患者的管理至关重要。尿毒症会引发厌食、恶心、厌肉和呕吐,这些紊乱最终会降低食欲,导致体重减轻和营养不良。蛋白质限制可以缓解这些尿毒症症状,改善患者健康状况和活力,但过度严格的蛋白质限制本身可能会导致营养不良。当能量摄入因设计原因或厌食而受到限制时,这种情况尤其可能发生。终末期肾病患者需要肾脏替代疗法来维持生命,尽管透析维持了生命,但它既不能替代正常的肾功能,也不能消除饮食管理的必要性。在这种可控的持续性尿毒症情况下,营养不良可能会悄然出现。长期以来,透析医生一直将营养不良视为尿毒症控制不佳和健康状况恶化的标志。现在,流行病学研究证实了这一假设,这些研究表明血清白蛋白和蛋白质分解代谢率(PCR)可区分死亡或患病风险高和低的透析患者。这种营养不良与健康和生存之间的关联在广泛的年龄、医学诊断和透析处方范围内都持续存在。由于PCR可以通过尿素动力学分析轻松测量,它已被推广为一种患者监测工具,并且在稳态条件下,它是确定蛋白质摄入量的可靠方法。尽管单次PCR测量不能整合日常饮食和代谢波动,并且存在±20%的固有不确定性,但连续测量可用于评估个体饮食蛋白质摄入量的变化。PCR定义了氮损失,当将其标准化为代谢活动的实际指标(代谢活跃体重)时,它可以揭示个体在氮利用方面的细微差异。然而,这些标准化蛋白质分解代谢率(NPCR)并不能测量或描述整体营养状况。所采用的标准化方案基于人群平均值,只是大致接近个体的真实代谢活动。因此,使用NPCR来定义营养需求可能会导致肥胖者摄入过多,消瘦者摄入不足。相反,营养充足应通过临床检查并与既定标准进行比较来定义。一旦确定了这种状态,并确定了理想的蛋白质和卡路里摄入量,NPCR就可以用于监测患者维持体内平衡的能力。